Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Nordic Group B.V.

Medicines register · Ireland

Nordic Group B.V. — licensed medicines

11 medicines held by Nordic Group B.V. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Nordimet 10 mg solution for injection in pre-filled pen EU/1/16/1124/002

Methotrexate

Nordic Group B.V.

—

Nordimet 12.5 mg solution for injection in pre-filled pen EU/1/16/1124/003

Methotrexate

Nordic Group B.V.

—

Nordimet 15 mg solution for injection in pre-filled pen EU/1/16/1124/004

Methotrexate

Nordic Group B.V.

—

Nordimet 17.5 mg solution for injection in pre-filled pen EU/1/16/1124/005

Methotrexate

Nordic Group B.V.

—

Nordimet 20 mg solution for injection in pre-filled pen EU/1/16/1124/006

Methotrexate

Nordic Group B.V.

—

Nordimet 22.5 mg solution for injection in pre-filled pen EU/1/16/1124/007

Methotrexate

Nordic Group B.V.

—

Nordimet 25 mg solution for injection in pre-filled pen EU/1/16/1124/008

Methotrexate

Nordic Group B.V.

—

Nordimet 7.5 mg solution for injection in pre-filled pen EU/1/16/1124/001

Methotrexate

Nordic Group B.V.

—

Teysuno 15 mg/4.35 mg/11.8 mg hard capsules EU/1/11/669/001-002

Tegafur, Gimeracil, Oteracil (as monopotassium salt)

Nordic Group B.V.

—

Teysuno 20 mg/5.8 mg/15.8 mg hard capsules EU/1/11/669/003-004

Gimeracil, Oteracil (as monopotassium salt), Tegafur

Nordic Group B.V.

—

Trasylol 10,000 KIU/ml, solution for injection or infusion PA2252/001/001

APROTININ CONCENTRATED SOLUTION

Nordic Group B.V.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/nordic-group-b-v

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.